BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moghadami M, Dadashpour N, Mokhtari AM, Ebrahimi M, Mirahmadizadeh A. The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study. Braz J Infect Dis 2019;23:419-26. [PMID: 31678055 DOI: 10.1016/j.bjid.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 MOHAMMAD MAHDI MAJZOOBI, SEPIDEH NAMDAR, ROYA NAJAFI-VOSOUGH, ALI ABBAS HAJILOOI, HOSSEIN MAHJUB. Prediction of Hepatitis disease using ensemble learning methods. J Prev Med Hyg 2022;63. [PMID: 36415304 DOI: 10.15167/2421-4248/jpmh2022.63.3.2515] [Reference Citation Analysis]
2 Bruce MG, Bruden D, Hurlburt D, Morris J, Bressler S, Thompson G, Lecy D, Rudolph K, Bulkow L, Hennessy T, Simons BC, Weng MK, Nelson N, McMahon BJ. Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology 2022;76:1180-9. [PMID: 35320592 DOI: 10.1002/hep.32474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 He WQ, Guo GN, Li C. The impact of hepatitis B vaccination in the United States, 1999-2018. Hepatology 2022;75:1566-78. [PMID: 34855999 DOI: 10.1002/hep.32265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 GBD 2019 Iran Collaborators. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022;399:1625-45. [PMID: 35397236 DOI: 10.1016/S0140-6736(21)02751-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 52.0] [Reference Citation Analysis]
5 Mokhtari AM, Barouni M, Moghadami M, Negahdaripour M, Mirahmadizadeh A. Estimating costs of hepatitis B vaccination in infants: experimental evidence of the expanded program on immunization in Southern Iran. J Public Health (Oxf) 2021:fdab118. [PMID: 33866375 DOI: 10.1093/pubmed/fdab118] [Reference Citation Analysis]
6 Mokhtari AM, Barouni M, Moghadami M, Hassanzadeh J, Dewey RS, Mirahmadizadeh A. Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis. Hum Vaccin Immunother 2021;17:1825-33. [PMID: 33734949 DOI: 10.1080/21645515.2020.1845522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dowran R, Malekzadeh M, Nourollahi T, Sarkari B, Sarvari J. The Prevalence of Hepatitis B Virus Markers among Students of Shiraz University of Medical Sciences. Adv Biomed Res 2021;10:7. [PMID: 33959564 DOI: 10.4103/abr.abr_173_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]